Human Immunodeficiency Virus Preexposure Prophylaxis: Meeting the Needs of Transgender Populations

被引：2
|
作者：
Krakower, Douglas S. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St, Boston, MA 02215 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2021年 / 73卷 / 07期
关键词：
HIV; HIV prevention; preexposure prophylaxis; transgender populations; clinical pharmacology;
D O I：
10.1093/cid/ciaa1158
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E2124 / E2126
页数：3
相关论文
共 50 条
  • [31] Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis
    Colby, Donn J.
    Kroon, Eugene
    Sacdalan, Carlo
    Gandhi, Monica
    Grant, Robert M.
    Phanuphak, Praphan
    Ananworanich, Jintanat
    Robb, Merlin L.
    Phanuphak, Nittaya
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 962 - 964
  • [32] Prophylaxis Against Human Immunodeficiency Virus
    Sayin-Kutlu, Selda
    KLIMIK JOURNAL, 2016, 29 (03) : 100 - 106
  • [33] Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia
    Aldredge, Amalia
    Roth, Grant
    Vaidya, Akanksha
    Paula Duarte, Ana
    Kundu, Suprateek
    Zheng, Ziduo
    Smith, Bradley L.
    Lora, Meredith
    Gruen, Judah
    Sheth, Anandi N.
    Sales, Jessica M.
    Cantos, Valeria D.
    AIDS, 2021, 35 (03) : 524 - 526
  • [34] Care of the Transgender Person Living with Human Immunodeficiency Virus
    Madden, Serina
    Cole, Justin
    NURSING CLINICS OF NORTH AMERICA, 2024, 59 (02) : 183 - 188
  • [35] Postexposure Prophylaxis Against Human Immunodeficiency Virus
    Tolle, Michael A.
    Schwarzwald, Heidi L.
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (02) : 161 - 166
  • [36] Nevirapine and postexposure prophylaxis for human immunodeficiency virus
    Haehl, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (07): : 883 - 883
  • [37] Iowa TelePrEP: A Public-Health-Partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a Rural State
    Hoth, Angela B.
    Shafer, Cody
    Dillon, Dena Behm
    Mayer, Randy
    Walton, George
    Ohl, Michael E.
    SEXUALLY TRANSMITTED DISEASES, 2019, 46 (08) : 507 - 512
  • [38] Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda
    Koss, Catherine A.
    Ayieko, James
    Mwangwa, Florence
    Owaraganise, Asiphas
    Kwarisiima, Dalsone
    Balzer, Laura B.
    Plenty, Albert
    Sang, Norton
    Kabami, Jane
    Ruel, Theodore D.
    Black, Douglas
    Camlin, Carol S.
    Cohen, Craig R.
    Bukusi, Elizabeth A.
    Clark, Tamara D.
    Charlebois, Edwin D.
    Petersen, Maya L.
    Kamya, Moses R.
    Havlir, Diane V.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (12) : 1853 - 1860
  • [39] Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center
    Marcus, Julia L.
    Levine, Kenneth
    Sewell, Whitney C.
    Solleveld, Patricia
    Mayer, Kenneth H.
    Krakower, Douglas S.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [40] Is Higher Adherence Required for Women Using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis?
    Niu, Xin
    Drain, Paul K.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (03) : 801 - 802
12345